GABAB receptor antagonists: from synthesis to therapeutic applications
- 30 November 1993
- journal article
- research article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 14 (11), 391-394
- https://doi.org/10.1016/0165-6147(93)90056-p
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- CGP 36742: The first orally active GABAB blocker improves the cognitive performance of mice, rats, and rhesus monkeysBehavioral and Neural Biology, 1993
- The actions of orally active GABAB receptor antagonists on GABAergic transmission in vivo and in vitroEuropean Journal of Pharmacology, 1993
- Increased acetylcholine and quisqualate responsiveness after blockade of GABAB receptorsEuropean Journal of Pharmacology, 1992
- CGP 35348, a new GABAB antagonist, prevents antinociception and muscle‐relaxant effect induced by baclofenBritish Journal of Pharmacology, 1991
- Inhibition of baolofen-induced hypothermia in mice by the novel GABAB antagonist CGP 35348Neuropharmacology, 1991
- CGP 35348: a centrally active blocker of GABAB receptorsEuropean Journal of Pharmacology, 1990
- 2-Hydroxy-saclofen: an improved antagonist at central and peripheral GABAB receptorsNeuroscience Letters, 1988
- Phaclofen: a GABAB blocker reduces long-duration inhibition in the neocortexEuropean Journal of Pharmacology, 1988
- A physiological role for GABAB receptors in the central nervous systemNature, 1988
- Phaclofen: a peripheral and central baclofen antagonistBrain Research, 1987